The Short-Term Cost-Effectiveness of Once-Daily Liraglutide Versus Once-Weekly Exenatide for the Treatment of Type 2 Diabetes Mellitus in the United States
Crossref DOI link: https://doi.org/10.1371/journal.pone.0121915
Published Online: 2015-04-07
Update policy: https://doi.org/10.1371/journal.pone.corrections_policy
Wang, Bruce
Roth, Joshua A.
Nguyen, Hiep
Felber, Eugene
Furnback, Wes
Garrison, Louis P.
Version of Record valid from 2015-04-07